-+ 0.00%
-+ 0.00%
-+ 0.00%

MOONLAKE IMMUNOTHERAPEUTICS SHARES SOAR 32..9% AS US FDA CLEARS PATH FOR SKIN DISEASE DRUG FILING

Reuters·01/08/2026 14:47:13

Please log in to view news